M.B.B.S-M.B.B.S 3rd Year Pathology Paper-II(Rajasthan University of Health Sciences (RUHS)-2012)

This question paper contains 3 printed pages]
II M.B.B.S.
1213-A/1214-B Path, (ii)
Second M.B.B.S. Examination, 2012 PATHOLOGY

Second Paper (Sections—A & B)

Time : Three Hours Max. Marks : 40
(Use separate Answer-books for Section—A and B)
Q. No. 1 in Section—A and Q. No. 5 in Section—B of 10 marks each are compulsory.

Attempt any TWO questions more from the rest of the questions in Section—A and Section—B.

SECTION—A (Marks : 20)

1. Describe PBF, Bone-marrow findings and laboratory diagnosis in Megaloblastic Anaemia. 10
2. Write short notes on following :— 5
(a) Sideroblast.
(b) Haemophilia.
(c) Sickle cell Anaemia.
(d) Cytogenetic abnormality in C.M.L.

3- Describe PBF and Bone marrow findings in the followings :—

(a) Aplastic Anaemia.
(b) Acute Myeloid Leukaemia M3 type. (Acute Promelocytic Leukaemia).
(c) Chronic Lymphocytic Leukaemia
(d) Multiple Myeloma.
4. Write short notes on the following :-
(a) Prothrombin time
(b) Cytochemistry of Acute Leukaemia.
(c) Hairy cell Leukaemia.
(d) Indication of Bone marrow aspiration.

SECTION—B (Marks : 20)

5. Define and classify Jaundice. Discuss the laboratory diagnostic approach of different type of Jaundice.   10
6. Outline the Laboratory diagnosis in the following :—  5
(a) Laboratory diagnosis in Rheumatic Heart Disease.
(b) Laboratory diagnosis in Myocardial Infarction.
(c) Laboratory diagnosis in Subacute Bacterial Endocarditis.
(d) Laboratory diagnosis in Chronic Glomerulonephritis.

7.Write short notes on following (Support with diagram) 5

(a)Enumerate Haemoparasites in Peripheral blood and Bone-marrow with diagrammatic illustration.
(b) Enumerate cyst and ova found in stool.
(c) Cell abnormality found in Urine.
(d) CSF findings in Pyogenic Meningitis. 
8.Write short notes on following (Support with diagram) •— 5
(a) Esbach's Albulinometer and its uses.
(b) Wintrobe's tube and its uses.
(c) Haemoglobin Pipette and its uses.
(d) Laboratory Diagnostic approach in Bronchogenic
carcinoma.